Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
bluebird bio, Inc. stock logo
BLUE
bluebird bio
$4.97
$4.55
$3.20
$28.60
$48.67M0.27439,337 shsN/A
Carvana Co. stock logo
CVNA
Carvana
$317.27
+3.0%
$280.52
$106.32
$351.43
$67.93B3.653.94 million shs2.50 million shs
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$640.14
+0.8%
$578.87
$437.37
$672.19
$196.39B1.322.37 million shs1.75 million shs
NVIDIA Corporation stock logo
NVDA
NVIDIA
$143.71
-1.2%
$125.72
$86.62
$153.13
$3.51T2.12274.42 million shs157.01 million shs
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$132.62
-0.5%
$134.58
$127.35
$159.64
$34.31B0.648.54 million shs9.81 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
bluebird bio, Inc. stock logo
BLUE
bluebird bio
0.00%0.00%-0.20%+27.44%-72.71%
Carvana Co. stock logo
CVNA
Carvana
0.00%-3.56%+1.87%+60.69%+177.60%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.00%+1.68%+4.87%+12.51%+38.97%
NVIDIA Corporation stock logo
NVDA
NVIDIA
0.00%+0.33%+8.26%+23.60%+7.30%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
0.00%-2.61%-1.08%-9.11%-8.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
bluebird bio, Inc. stock logo
BLUE
bluebird bio
2.5946 of 5 stars
3.15.00.00.00.01.71.3
Carvana Co. stock logo
CVNA
Carvana
3.3006 of 5 stars
2.32.00.00.92.02.51.9
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
4.9437 of 5 stars
2.25.04.23.02.23.33.8
NVIDIA Corporation stock logo
NVDA
NVIDIA
4.8671 of 5 stars
3.55.01.73.03.32.51.9
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
bluebird bio, Inc. stock logo
BLUE
bluebird bio
2.25
Hold$44.60797.38% Upside
Carvana Co. stock logo
CVNA
Carvana
2.67
Moderate Buy$283.59-10.61% Downside
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.32
Hold$593.40-7.30% Downside
NVIDIA Corporation stock logo
NVDA
NVIDIA
2.93
Moderate Buy$173.0520.42% Upside
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
2.69
Moderate Buy$132.880.20% Upside

Current Analyst Ratings Breakdown

Latest XLV, CVNA, NVDA, BLUE, and GS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/17/2025
Carvana Co. stock logo
CVNA
Carvana
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$290.00 ➝ $295.00
6/17/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$170.00 ➝ $200.00
6/16/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$175.00
6/10/2025
Carvana Co. stock logo
CVNA
Carvana
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$325.00 ➝ $375.00
5/29/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/29/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00 ➝ $170.00
5/29/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$150.00 ➝ $180.00
5/29/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$155.00 ➝ $170.00
5/29/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetStrong-Buy ➝ Strong-Buy$150.00 ➝ $165.00
5/29/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$205.00 ➝ $210.00
5/29/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$168.00 ➝ $170.00
(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
bluebird bio, Inc. stock logo
BLUE
bluebird bio
$103.95M0.47N/AN/A$35.59 per share0.14
Carvana Co. stock logo
CVNA
Carvana
$13.67B4.97$2.20 per share144.05$6.47 per share49.04
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$126.85B1.55$54.11 per share11.83$350.27 per share1.83
NVIDIA Corporation stock logo
NVDA
NVIDIA
$130.50B26.87$3.02 per share47.58$3.44 per share41.78
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
bluebird bio, Inc. stock logo
BLUE
bluebird bio
-$211.91M-$41.32N/AN/AN/A-565.74%-322.46%-53.17%8/12/2025 (Estimated)
Carvana Co. stock logo
CVNA
Carvana
$210M$2.85111.3162.451.202.68%44.86%4.99%7/30/2025 (Estimated)
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$14.28B$43.0914.8512.290.8711.86%13.76%0.87%7/16/2025 (Estimated)
NVIDIA Corporation stock logo
NVDA
NVIDIA
$72.88B$3.1046.3536.111.2851.69%105.09%72.19%8/27/2025 (Estimated)
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/A27.62N/AN/AN/AN/AN/A

Latest XLV, CVNA, NVDA, BLUE, and GS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/16/2025Q2 2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$9.82N/AN/AN/A$13.53 billionN/A
5/28/2025Q1 2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
$0.87$0.81-$0.06$0.76$43.09 billion$44.06 billion
5/7/2025Q1 2025
Carvana Co. stock logo
CVNA
Carvana
$0.75$1.51+$0.76$1.51$3.94 billion$4.23 billion
4/14/2025Q1 2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$12.57$14.12+$1.55$14.12$14.99 billion$15.06 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
bluebird bio, Inc. stock logo
BLUE
bluebird bio
N/AN/AN/AN/AN/A
Carvana Co. stock logo
CVNA
Carvana
N/AN/AN/AN/AN/A
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$12.001.87%N/A27.85%13 Years
NVIDIA Corporation stock logo
NVDA
NVIDIA
$0.040.03%N/A1.29%1 Years
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$2.341.76%N/AN/AN/A

Latest XLV, CVNA, NVDA, BLUE, and GS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/28/2025
NVIDIA Corporation stock logo
NVDA
NVIDIA
quarterly$0.010.03%6/11/20256/11/20257/3/2025
4/15/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
quarterly$3.002.3%5/30/20255/30/20256/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
bluebird bio, Inc. stock logo
BLUE
bluebird bio
0.37
0.51
0.33
Carvana Co. stock logo
CVNA
Carvana
2.97
3.81
2.70
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.41
0.68
0.68
NVIDIA Corporation stock logo
NVDA
NVIDIA
0.10
3.39
2.96
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
bluebird bio, Inc. stock logo
BLUE
bluebird bio
87.43%
Carvana Co. stock logo
CVNA
Carvana
56.71%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
NVIDIA Corporation stock logo
NVDA
NVIDIA
65.27%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
bluebird bio, Inc. stock logo
BLUE
bluebird bio
5209.79 million9.59 millionOptionable
Carvana Co. stock logo
CVNA
Carvana
17,400214.14 million177.48 millionOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
46,500306.84 million305.15 millionOptionable
NVIDIA Corporation stock logo
NVDA
NVIDIA
36,00024.40 billion23.38 billionOptionable
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/A258.42 millionN/ANot Optionable

Recent News About These Companies

6 ETFs to Invest in June
Healthcare ETFs Slide as UnitedHealth Plunges
SPDR Health Care Select Sector (XLV)
Health Care Sector In 2025: Buy Abbott Labs

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
bluebird bio stock logo

bluebird bio NASDAQ:BLUE

$4.97 0.00 (0.00%)
As of 06/2/2025

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. The company's clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has license agreement with Orchard Therapeutics Limited. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.

Carvana stock logo

Carvana NYSE:CVNA

$317.26 +9.36 (+3.04%)
As of 03:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Carvana Co., together with its subsidiaries, operates an e-commerce platform for buying and selling used cars in the United States. Its platform allows customers to research and identify a vehicle; inspect it using company's 360-degree vehicle imaging technology; obtain financing and warranty coverage; purchase the vehicle; and schedule delivery or pick-up from their desktop or mobile devices. The company also operates auction sites. The company was founded in 2012 and is based in Tempe, Arizona.

The Goldman Sachs Group stock logo

The Goldman Sachs Group NYSE:GS

$640.14 +4.90 (+0.77%)
As of 03:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.

NVIDIA stock logo

NVIDIA NASDAQ:NVDA

$143.71 -1.77 (-1.22%)
As of 03:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.

Health Care Select Sector SPDR Fund stock logo

Health Care Select Sector SPDR Fund NYSEARCA:XLV

$132.62 -0.63 (-0.47%)
As of 03:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.